Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Sirona Biochem Corp V.SBM

Alternate Symbol(s):  SRBCF

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to... see more

Bullboard (TSXV:SBM)

View:
Comment by Turtle4on Feb 02, 2023 10:22am

RE:RE:RE:WTF

I think one day before Sirona publishes the first financials with Abbvies royalties, Howie will say something like: "We at Sirona Biochem deliberately opted for a lower royalty payment ...more  
Comment by lscfaon Feb 02, 2023 2:10am

RE:RE:WTF

I still think Sirona had no choice in the matter of how large the upfront payment was. Abbvie told them to take it or shove it.    
Comment by forhandlarenon Feb 02, 2023 1:05am

RE:WTF

Daily bids are removed after the close and can give misleading impression. However, I'm concerned - not so much for single digits because most of the sellers triggers a loss, but lack ...more  
Comment by MirrorWorldManon Feb 01, 2023 8:24pm

RE:WTF

They cannot afford a CEO now that Howie has lost all of our Market Cap. So that will be the excuse for further borrowing at astronomical rates or more dilution. Howie has run out of digits to stick in ...more  
Post by bealerton Feb 01, 2023 4:33pm

WTF

Any comments on the closing bid/ask? .06 bid .105ask, last trade at 10 cents. My comment is that Howard should be fired immediately for incompetence at SBM, along with his colleagues. That's MY ...more  
Comment by MirrorWorldManon Jan 31, 2023 1:00pm

RE:When will we see the $0.09?

I wonder if Howie & Co. really understand business evaluation. Always trying to sell shareholders on future royalty payments and then admitting they are looking for current financing. 
Post by Turtle4on Jan 31, 2023 11:16am

When will we see the $0.09?

Before or after the anti aging study results?
Post by lscfaon Jan 30, 2023 10:42am

botox, schmotox

https://www.genengnews.com/topics/drug-discovery/mrna-loaded-natural-delivery-vehicle-reduces-wrinkles-in-aging-skin/
Comment by lscfaon Jan 25, 2023 1:59pm

RE:Only cash flow from Abbvie will change the share price

an upfront payment for licensing 039 may come first......Abbvie product still 12 months away?
Comment by Pandoraon Jan 25, 2023 1:28pm

RE:Only cash flow from Abbvie will change the share price

"Hopefully it actually happens before I die of old age." I can certainly agree with you on that one. I have at least a half dozen of these stocks and years just keep going by with little to ...more  
Comment by MirrorWorldManon Jan 21, 2023 8:27pm

RE:RE:RE:RE:PRC Partners anticipates that a major licensing deal ....

There is no shortage of cash with AbbVie and their new desire for their Gepants to replace Triptans on top of the Botox success means lots of revenue to continue div increases. 
Comment by Pandoraon Jan 21, 2023 7:51pm

RE:RE:RE:PRC Partners anticipates that a major licensing deal ....

And, just to humour us: AbbVie, An Honorary Dividend King  AbbVie Inc (NYSE: ABBV) is technically not a Dividend King or even a Dividend Aristocrat, far from it. Still, it has garnered ...more  
Comment by biofoolon Jan 21, 2023 1:38pm

RE:RE:PRC Partners anticipates that a major licensing deal ....

this was written and published by PRC Partners beginning of last year. shortly before warrants expired. than it was removed by PRC Partners. i posted this to show that it's the same scribble as ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities